145 related articles for article (PubMed ID: 21112866)
1. Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid.
Corsello SM; Paragliola RM; Locantore P; Ingraudo F; Ricciato MP; Rota CA; Senes P; Pontecorvi A
Hormones (Athens); 2010; 9(4):338-42. PubMed ID: 21112866
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism.
Lee IT; Sheu WH; Tu ST; Kuo SW; Pei D
J Bone Miner Metab; 2006; 24(3):255-8. PubMed ID: 16622740
[TBL] [Abstract][Full Text] [Related]
3. Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report.
Noriega Aldave AP; Jaiswal S
J Med Case Rep; 2014 Oct; 8():353. PubMed ID: 25342294
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid.
Ferraz-de-Souza B; Martin RM; Correa PH
J Bone Miner Metab; 2013 May; 31(3):360-5. PubMed ID: 23076294
[TBL] [Abstract][Full Text] [Related]
5. High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid.
Zuradelli M; Masci G; Biancofiore G; Gullo G; Scorsetti M; Navarria P; Tancioni F; Berlusconi M; Giordano L; Santoro A
Oncologist; 2009 May; 14(5):548-56. PubMed ID: 19411682
[TBL] [Abstract][Full Text] [Related]
6. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
7. Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.
Polyzos SA; Anastasilakis AD; Litsas I; Efstathiadou Z; Kita M; Arsos G; Moralidis E; Papatheodorou A; Terpos E
J Bone Miner Metab; 2010 Nov; 28(6):706-12. PubMed ID: 20533067
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic hypocalcaemia after treatment with zoledronic acid in a patient with multiple myeloma.
Singh D; Khaira NS; Sekhon JS
Ann Oncol; 2004 Dec; 15(12):1848. PubMed ID: 15550594
[No Abstract] [Full Text] [Related]
9. [Primary hyperparathyroidism. An alternative to the surgery].
Díaz Guardiola P; Vega Piñero B; Alameda Hernando C; Pavón de Paz I; Iglesias Bolaños P; Guijarro de Armas G
Endocrinol Nutr; 2009 Mar; 56(3):132-5. PubMed ID: 19627726
[TBL] [Abstract][Full Text] [Related]
10. Risk factors contributing to the development of hypocalcemia after zoledronic acid administration in patients with bone metastases of solid tumor.
Hanamura M; Iwamoto T; Soga N; Sugimura Y; Okuda M
Biol Pharm Bull; 2010; 33(4):721-4. PubMed ID: 20410614
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing serum calcium levels and the incidence of hypocalcemia after parathyroidectomy in primary hyperparathyroidism patients.
Mu Y; Zhao Y; Zhao J; Zhao Q; Zhang Y; Li Y; Kou J; Dionigi G; Bian X; Sun H
Front Endocrinol (Lausanne); 2023; 14():1276992. PubMed ID: 38116316
[TBL] [Abstract][Full Text] [Related]
12. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
13. Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent prostate cancer and extensive bone metastases.
Gulley JL; Wu S; Arlen PM; Dahut WL
Clin Genitourin Cancer; 2007 Sep; 5(6):403-5. PubMed ID: 17956715
[TBL] [Abstract][Full Text] [Related]
14. Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.
Kaur U; Chakrabarti SS; Gambhir IS
Curr Drug Saf; 2016; 11(3):267-9. PubMed ID: 27113952
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program.
Major PP; Coleman RE
Semin Oncol; 2001 Apr; 28(2 Suppl 6):17-24. PubMed ID: 11346861
[TBL] [Abstract][Full Text] [Related]
16. Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
Tanvetyanon T; Choudhury AM
Ann Pharmacother; 2004 Mar; 38(3):418-21. PubMed ID: 14970365
[TBL] [Abstract][Full Text] [Related]
17. Severe hypocalcemia complicated by postsurgical hypoparathyroidism and hungry bone syndrome in a patient with primary hyperparathyroidism, Graves' disease, and acromegaly.
Tachibana S; Sato S; Yokoi T; Nagaishi R; Akehi Y; Yanase T; Yamashita H
Intern Med; 2012; 51(14):1869-73. PubMed ID: 22821103
[TBL] [Abstract][Full Text] [Related]
18. Successful Management of Severe Hypercalcemia with Zoledronic Acid: A Report of Two Pediatric Cases.
Kilci F; Jones JH; Çizmecioğlu-Jones FM
J Clin Res Pediatr Endocrinol; 2024 May; 16(2):224-228. PubMed ID: 36264042
[TBL] [Abstract][Full Text] [Related]
19. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
20. Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions.
Jones SG; Dolan G; Lengyel K; Myers B
Br J Haematol; 2002 Nov; 119(2):576-7. PubMed ID: 12406106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
